Paraneoplastic pemphigus: an association with fludarabine?
โ Scribed by C. Gooptu; T.J. Littlewood; P. Frith; C.C. Lyon; A.J. Carmichael; S. Oliwiecki; A. Macwhannell; M. Amagai; T. Hashimoto; D. Dean; J. Allen; F. Wojnarowska
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 524 KB
- Volume
- 144
- Category
- Article
- ISSN
- 0007-0963
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Paraneoplastic pemphigus (PNP) is an autoimmune disorder occurring in the setting of an underlying neoplasm in which patients have polymorphous skin and mucous membrane lesions. We describe a patient with non-Hodgkin's lymphoma who developed bullous, ulcerating lesions in an area being treated with
Fludarabine monophosphate (FAMP), the 2-fluoro, 5'phosphate derivative of 9-/3-D-arabinofuranosyl adenine (ara-A), is a purine nucleoside antimetabolite presently undergoing clinical testing for the treatment of a variety of malignancies including lymphoproliferative disorders and acute leukemia. We
have transfusion necessity, after the 3 month interval from the beginning of the therapy; in 14% of patients Erythropoietin was used to correct the anemic syndrome. The dosage was 10000 IU 3 times per week subcutaneous. Since no severe granulocytopenia cases were reported the administration of GM-CS